Literature DB >> 27579642

Muscling In on Cancer.

Alejandro Lucia1, Manuel Ramírez1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27579642     DOI： 10.1056/NEJMcibr1606456

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Leveraging premalignant biology for immune-based cancer prevention.

Authors:  Avrum Spira; Mary L Disis; John T Schiller; Eduardo Vilar; Timothy R Rebbeck; Rafael Bejar; Trey Ideker; Janine Arts; Matthew B Yurgelun; Jill P Mesirov; Anjana Rao; Judy Garber; Elizabeth M Jaffee; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

2.  Relationship between skeletal muscle function, body composition, and weight loss in patients with advanced pancreatic and gastrointestinal cancers.

Authors:  P Cresta Morgado; M Daud; M Carballido; G Méndez; S Iseas; V Lobbe; G De Simone; A Navigante
Journal:  Support Care Cancer       Date:  2018-08-18       Impact factor: 3.603

3.  Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieu.

Authors:  Yvonne Huber; Nadine Gehrke; Jana Biedenbach; Susanne Helmig; Perikles Simon; Beate K Straub; Ina Bergheim; Tobias Huber; Detlef Schuppan; Peter R Galle; Marcus A Wörns; Marcus Schuchmann; Jörn M Schattenberg
Journal:  Cell Death Dis       Date:  2017-06-22       Impact factor: 8.469

4.  Influence of a Moderate-Intensity Exercise Program on Early NK Cell Immune Recovery in Pediatric Patients After Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Authors:  Carolina Chamorro-Viña; Jaime Valentín; Lucía Fernández; Marta González-Vicent; Margarita Pérez-Ruiz; Alejandro Lucía; S Nicole Culos-Reed; Miguel Ángel Díaz; Antonio Pérez-Martínez
Journal:  Integr Cancer Ther       Date:  2016-11-30       Impact factor: 3.279

5.  Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.

Authors:  Takayuki Shiroyama; Izumi Nagatomo; Shohei Koyama; Haruhiko Hirata; Sumiyuki Nishida; Kotaro Miyake; Kiyoharu Fukushima; Yuya Shirai; Yuichi Mitsui; So Takata; Kentaro Masuhiro; Moto Yaga; Kota Iwahori; Yoshito Takeda; Hiroshi Kida; Atsushi Kumanogoh
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

6.  Does sarcopenia affect postoperative short- and long-term outcomes in patients with lung cancer?-a systematic review and meta-analysis.

Authors:  Yo Kawaguchi; Jun Hanaoka; Yasuhiko Ohshio; Keigo Okamoto; Ryosuke Kaku; Kazuki Hayashi; Takuya Shiratori; Akira Akazawa
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

7.  Effect of Body Composition Change during Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.

Authors:  Sachiyo Onishi; Masahiro Tajika; Tsutomu Tanaka; Keisaku Yamada; Tomoyasu Kamiya; Tetsuya Abe; Eiji Higaki; Hironori Fujieda; Takuya Nagao; Yoshitaka Inaba; Kei Muro; Masahito Shimizu; Yasumasa Niwa
Journal:  J Clin Med       Date:  2022-01-20       Impact factor: 4.241

8.  Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer.

Authors:  Han Gyul Yoon; Dongryul Oh; Yong Chan Ahn; Jae Myoung Noh; Hongryull Pyo; Won Kyung Cho; Yun Mi Song; Minsu Park; Na Young Hwang; Jong-Mu Sun; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

Review 9.  Muscle-Organ Crosstalk: The Emerging Roles of Myokines.

Authors:  Mai Charlotte Krogh Severinsen; Bente Klarlund Pedersen
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

10.  Impact of cancer rehabilitation on the prognosis of patients with hepatocellular carcinoma.

Authors:  Ryuki Hashida; Takumi Kawaguchi; Shunji Koya; Keisuke Hirota; Norihiro Goshima; Teruhito Yoshiyama; Takashi Otsuka; Masafumi Bekki; Sohei Iwanaga; Dan Nakano; Takashi Niizeki; Hiroo Matsuse; Atsushi Kawaguchi; Naoto Shiba; Takuji Torimura
Journal:  Oncol Lett       Date:  2020-01-24       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.